Main Article Content
Considering the prevalence of diabetes mellitus, the possibility of early and rapid progress of complications, a large number of undiagnosed cases and disappointing forecasts of the WHO on the prospects of diabetes mellitus spreading in the world, timely and accurate diagnosis of carbohydrate metabolism disorders is important. The glycated hemoglobin — an indicator that, while using the standardized methods, provides an integrated view of the glycemia level during a long period of time and allows timely detection of carbohydrate metabolism disorders. When using the glycated hemoglobin as a diagnostic criterion for detecting carbohydrate metabolism disorders or degree of diabetes mellitus compensation, the correct approach to the choice of the method of this index determination, considering its analytical reliability, is important.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
International Diabetes Federation, Diabetes Atlas. — 6th edition. — 2013. — 159 р.
Gonen B.A. Hemoglobin A1: An indicator of the metabolic control of diabetic patients / B.A. Gonen, A.H. Rubinstein, H. Rochman et al. // The Lancet. — 1977. — Vol. 310. — Р. 734-737.
Koenig R.J. Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus / R.J. Koenig, C.M. Peterson, R.L. Jones et al. // New England Journal of Medicine. — 1976. — Vol. 295, № 8. — P. 417-420.
Korolev V. A. Metod yzoyelektrofokusyrovanyya y fotokolorymetryya dlya opredelenyya hemohlobyna A1s / V. A. Korolev, V. Y. Molchanov // Byomedytsynskaya khymyya. — 2006. — T.52, №2. — P. 200-210.
Pyters-Kharmel Ye. Sakharnyy dyabet: dyahnostyka y lechenye / Ye. Pyters-Kharmel, R. Matur. Per. s anhl. — M.: Praktyka, 2008. — 496 p.
American Diabetes Association Standards of Medical Care in Diabetes — 2010 // Diabetes Care. — 2010. — Vol. 33 (1). — P. 511-561.
International expert committee report on the role of the A1c assay in the diagnosis of diabetes // Diabetes Care. — 2009. — Vol. 32 (7). — P. 1327-1334.
Approved IFCC reference method for the measurement of HbA1c in human blood // Clin. Chem. Lab. Med. — 2002. — Vol. 40 (1). — Р. 78-89.
DCCT. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial // Diabetes. — 1995. — Vol. 44 (8). — P. 968-983.
Stratton J.M. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective, observational study / J.M. Stratton, A.I. Adler, A.W. Neil et al. // BMJ. — 2000. — Vol. 321. — Р. 405-412.
Hnudy L. Rezul'taty y vlyyanye yssledovanyy ACCORD y ADVANCE / L. Hnudy // Diabetes voice. — 2009. — Vol. 54, №1. — P. 29-32.